Danielle Van Citters

Title: The Innovative Contributions of Danielle Van Citters

Introduction

Danielle Van Citters is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. Her work focuses on creating molecules that can effectively target cancer cells, showcasing her commitment to advancing medical science.

Latest Patents

Danielle holds a patent for "Antigen binding proteins binding to 5T4 and 4-1BB and related compositions and methods." This patent describes protein molecules that specifically bind to 5T4 and/or 4-1BB, which are crucial for cancer treatment. The molecules may include at least one humanized binding domain and can enhance effector cell activation, proliferation, survival, and cytotoxicity. Additionally, the patent covers pharmaceutical compositions that utilize these innovative protein molecules.

Career Highlights

Throughout her career, Danielle has worked with prominent companies in the biotechnology sector, including Aptevo Research and Development LLC and Alligator Bioscience AB. Her experience in these organizations has allowed her to contribute to groundbreaking research and development efforts.

Collaborations

Danielle has collaborated with talented individuals such as David Bienvenue and Gabriela Hernandez-Hoyos. These partnerships have further enriched her work and expanded the impact of her innovations.

Conclusion

Danielle Van Citters is a pioneering inventor whose work in antigen binding proteins is making strides in cancer treatment. Her contributions to biotechnology reflect her dedication to improving healthcare through innovative solutions.